Immutep Ltd ADR (IMMP)

3.640
-0.280(-7.14%)
After Hours
3.590
-0.050(-1.374%)
- Real-time Data
  • Volume:
    374,448
  • Bid/Ask:
    3.580/3.770
  • Day's Range:
    3.570 - 3.870
  • Type:Equity
  • Market:United States
  • ISIN:US45257L1089
  • CUSIP:00045257L108

IMMP Overview

Prev. Close
3.92
Day's Range
3.57-3.87
Revenue
-
Open
3.73
52 wk Range
1.53-7.89
EPS
-
Volume
374,448
Market Cap
333.14M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
351,815
P/E Ratio
-
Beta
-
1-Year Change
92.59%
Shares Outstanding
850,922,801
Next Earnings Date
Dec 01, 2021
What is your sentiment on Immutep Ltd ADR?
or
Market is currently closed. Voting is open during market hours.

Immutep Ltd ADR News

Immutep Ltd ADR Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralStrong SellSellStrong SellBuy
Technical IndicatorsBuyNeutralStrong SellStrong SellStrong Buy
SummaryNeutralSellStrong SellStrong SellStrong Buy

Immutep Ltd ADR Company Profile

Immutep Ltd ADR Company Profile

Employees
0

Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ‘eftilagimod alpha’ or ‘efti’, which is a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer termed AIPAC; and is being evaluated as a combination therapy in head and neck squamous cell carcinoma and non-small cell lung carcinoma in a Phase II clinical trial called TACTI-002 and an investigator initiated Phase I trial called INSIGHT in advanced solid tumors. Its other products include IMP761, IMP701 and IMP731, all of which are related to lymphocyte activation gene 3, a gene linked to the regulation of T cells in immune responses. It has partnerships with GlaxoSmithKline, Novartis, CYTLIMIC Inc., INSIGHT, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia.

Read More
  • IMMP's Eftilagimod Alpha advances to Phase II study in COVID-19 patients, 6 of whom have already been discharged from hospital after taking injections of efti alpha.
    0
    • any news ?? soon
      0
      • this supposed to go up ,it was news about progress of clinical trials
        0
        • At least 5$ this month.
          0
        • hopefully
          0
      • IMMUTEP secured US patent for cancer drug. Stock jumps 15%. Will go further up in coming months.
        0
        • "IMMP is planning to increase the efti manufacturing process from 200L to 2000L capacity bioreactors at the Wuxi Biologics manufacturing plant with major scale up steps taking place throughout 2021"
          0
          • so what? -8%
            0
          • EL KAT It'll shoot up soon. Momentum's been building up nicely.
            0
        • l think this is going nowhere 😕
          1
          • lol consolidation should be be done soon .
            0
            • delayed reaction on today's news . READ !
              0
              • analyst are underestimate target price by a long shot ! more news could be coming as early as today!
                0
                • more news about ??
                  0
              • big boys kept their wallets full . hope it goes up 2 bucks over night
                0
                • 4.00 coming
                  0
                  • up up up and away
                    0
                    • might trade heavy even after close . some more good news should come out !
                      0
                      • on the news alone this should be buying this up . buying might come heavy near the close ?
                        0
                        • where this may go ??
                          0
                          • Flip a coin on this one.  I bought a large amount on the news and increased activity.  Will hold long to see where it goes.
                            1
                          • they have a lot of pipeline and trials..lets see
                            0
                        • back to 2 ? I see this filling upper gap . 4.25 buy close
                          0
                          • Green premarket ?????
                            0
                            • https://www.immutep.com/pipeline/clinical-pipeline.html
                              0
                              • what can we accept ?? up in the future ??
                                0
                              • I have some shares with them and bought it during its surge. big mistake. hopefully they become successful with the pipelines to regain the capital.
                                0
                            • back to $2
                              3
                              • It seems safe to hold this one compared to GLSI & SLS. Pre-market volume is 6 times higher than yesterdays volume! Lets see how this reflect when market opens!
                                3
                                • When a stock falls with bigger volume than it rose that's not a good sign.
                                  0
                              • Avoid chasing stocks. IMMP is in pullback mode.
                                1
                                • Get in before this one sky rocket to mars tomorrow.. expect it open between 9=11 😱↗️↗️
                                  2
                                  • Hoping. Fly like $GLSI
                                    0
                                  • Mr Travel time Lol it looks more like XBIO than GLSI
                                    0
                                  • This didn't age well
                                    0
                                • Frankly speaking, is it appropriate to buy know?
                                  0
                                  • if its continue tomorrow yes its good to buy ..
                                    0
                                • what can happen with this tomorrow?? any idea
                                  0
                                  • There is a chance to up tomorrow when you compare with other ones such as GLSI, SLS..
                                    0
                                  • Doddapaneni Venkateshthanks brother
                                    0
                                • Can i bye now ans sell tom
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.